Macrogenics (MGNX) Total Liabilities (2012 - 2026)

Macrogenics (MGNX) has reported Total Liabilities for 15 consecutive years, with $196.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Liabilities rose 35.22% year-over-year to $196.7 million; the TTM figure through Mar 2026 stood at $196.7 million (up 35.22% YoY), while the FY2025 annual figure was $201.3 million, up 38.23% from the prior year.
• Total Liabilities eased to $196.7 million in Q1 2026 per MGNX's latest filing, from $201.3 million in the prior quarter.
• Across five years, Total Liabilities topped out at $234.2 million in Q1 2023 and bottomed at $72.4 million in Q3 2022.
• Historically, Total Liabilities has averaged $150.7 million across 5 years, with a median of $145.4 million in 2025.
• Annual changes were most pronounced in 2023 — Total Liabilities surged 151.24% — and 2024, when it sank 39.32%.
• Macrogenics' Total Liabilities stood at $138.5 million in 2022, then rose by 5.31% to $145.8 million in 2023, then declined by 0.14% to $145.6 million in 2024, then soared by 38.23% to $201.3 million in 2025, then fell by 2.28% to $196.7 million in 2026.
• Business Quant data shows MGNX's Total Liabilities at $196.7 million in Q1 2026, $201.3 million in Q4 2025, and $203.8 million in Q3 2025.